Expertise in
1
conditions

Nianyong F. Chen

Cancer Center And State Key Laboratory Of Respiratory Health And Multimorbidity, 
Chengdu, CN 
Expertise in
1
conditions
Cancer Center And State Key Laboratory Of Respiratory Health And Multimorbidity, 
Chengdu, CN 

Overview

Nianyong Chen practices practicing medicine in Chengdu, China.

Chen is highly rated in 1 condition, according to our data. Their clinical expertise encompasses Nasopharyngeal Carcinoma, Magnesium Deficiency, Cerebral Hypoxia, and Triple-Negative Breast Cancer.

They are actively involved in clinical research, co-authoring 63 peer reviewed articles and participating in 1 clinical trial.

Locations

Cancer Center And State Key Laboratory Of Respiratory Health And Multimorbidity, Chengdu, China
Other Locations
Department Of Head And Neck Oncology, China

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

1 Clinical Trials

A Randomized, Double-blind, Adaptive, Phase II/III Study of GSK3359609 or Placebo in Combination With Pembrolizumab for First-Line Treatment of PD-L1 Positive Recurrent/Metastatic Head and Neck Squamous Cell Carcinoma
A Randomized, Double-blind, Adaptive, Phase II/III Study of GSK3359609 or Placebo in Combination With Pembrolizumab for First-Line Treatment of PD-L1 Positive Recurrent/Metastatic Head and Neck Squamous Cell Carcinoma
Enrollment Status: Terminated
Publish Date: July 10, 2024
Intervention Type: Drug
Study Drugs: Feladilimab, Pembrolizumab
Study Phase: Phase 3

63 Total Publications

Correction: Granzyme B-based CAR-T cells targeting membrane-bound HSP70 suppress solid tumor growth and metastasis.
Correction: Granzyme B-based CAR-T cells targeting membrane-bound HSP70 suppress solid tumor growth and metastasis.
Journal: Oncogene
Published: July 28, 2026

Frequently Asked Questions about Nianyong F. Chen

Is Nianyong F. Chen a top-rated expert for Nasopharyngeal Carcinoma?

MediFind is an objective health platform that identifies experts based on real-world data. Nianyong F. Chen is classified as an Advanced expert for Nasopharyngeal Carcinoma, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.

Does Nianyong F. Chen participate in research or clinical trials?

Yes. Nianyong F. Chen has published 63 articles and abstracts on conditions like Nasopharyngeal Carcinoma. You can view a list of Nianyong F. Chen's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Chen's expertise for a condition
ConditionClose
      View All 9 Experienced Conditions
      Want to save this expert for later?
      Sign Up
      Not sure about your diagnosis?
      Check Your Symptoms
       
       
       
       
      Learn about our expert tiers
      Learn More
      Are you the provider on this profile?
      Claim Profile